Results 231 to 240 of about 105,740 (327)

Biomarkers of Leucine‐Rich Repeat Kinase 2 (LRRK2) and Lysosomal Dysfunction in Progressive Supranuclear Palsy

open access: yesMovement Disorders, EarlyView.
Abstract Background Common and rare genetic variants in leucine‐rich repeat kinase 2 (LRRK2) have been linked with sporadic and familial Parkinson's disease (PD). Recently, we discovered that common genetic variation near the LRRK2 locus determined survival in progressive supranuclear palsy (PSP).
Louise‐Kristine Nielsen   +27 more
wiley   +1 more source

Untargeted Plasma Proteomic Signatures and Late Graft Failure in Kidney Transplant Recipients. [PDF]

open access: yesTransplantation
Shehab NBN   +14 more
europepmc   +1 more source

Prognosis in Parkinson's Disease: An Individual Patient Data Meta‐Analysis of Six European Incidence Cohorts

open access: yesMovement Disorders, EarlyView.
Abstract Background An accurate understanding of prognosis in Parkinson's disease (PD) is important for patient information provision, personalized treatment, and clinical trial design, but most previous research has been biased towards younger, healthier patients.
Angus D. Macleod   +72 more
wiley   +1 more source

Healthy Dietary Patterns and Risk of Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Abstract Background Although healthy dietary patterns have been suggested to be associated with decreased Parkinson's disease (PD) risk, their protective role remains uncertain. Objective To examine associations between eight dietary patterns and PD risk in two United States (US) cohorts followed for up to 32 years.
Xiao Chen   +8 more
wiley   +1 more source

On Order Restricted Inference in Multi‐Step Stage Life Testing for a General Family of Distributions

open access: yesNaval Research Logistics (NRL), EarlyView.
ABSTRACT Recently, k$$ k $$‐step stage life testing (SLT) has been proposed by Laumen and Cramer (2021) as a natural extension of progressive censoring with fixed censoring times (PC‐FCT) as well as of simple step‐stress accelerated life testing (SSALT).
Erhard Cramer   +2 more
wiley   +1 more source

Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes

open access: yesObesity, EarlyView.
ABSTRACT Objective The real‐world evidence on the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and cancer risk remains limited and mixed. Methods In 2013–2020 national Medicare claims data, we included cancer‐naïve patients with type 2 diabetes (T2D). We identified those who initiated GLP‐1 RA, sodium‐glucose cotransporter 2
Ying Lu   +13 more
wiley   +1 more source

Dogs' reactions to motivations and emotions in conspecific and heterospecific vocalizations. [PDF]

open access: yesSci Rep
Faragó T   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy